The urine albumin creatine ratio has been widely used as a conventional biomarker for the onset of DKD and its progression to end-stage renal disease, but there are some differences between the clinical manifestations and histopathological damage of DKD. The gene discussed is ALB; the disease is stage 5 chronic kidney disease.